RoActemra indeholder det aktive stof tocilizumab, et monoklonalt antistof, som blokerer virkningen af et specielt protein (cytokin), som kaldes interleukin- 6.
RoActemra contains the active substance tocilizumab, a monoclonal antibody that blocks the action of a specific protein (cytokine) called interleukin-6.